ConspectusArtificial metalloenzymes (ArMs) result from
anchoring a metal-containing
moiety within a macromolecular scaffold (protein or oligonucleotide).
The resulting hybrid catalyst combines attractive features of both
homogeneous catalysts and enzymes. This strategy includes the possibility
of optimizing the reaction by both chemical (catalyst design) and
genetic means leading to achievement of a novel degree of (enantio)selectivity,
broadening of the substrate scope, or increased activity, among others.
In the past 20 years, the Ward group has exploited, among others,
the biotin–(strept)avidin technology to localize a catalytic
moiety within a well-defined protein environment. Streptavidin has
proven versatile for the implementation of ArMs as it offers the following
features: (i) it is an extremely robust protein scaffold, amenable
to extensive genetic manipulation and mishandling, (ii) it can be
expressed in E. coli to very high titers (up to >8
g·L–1 in fed-batch cultures), and (iii) the
cavity surrounding the biotinylated cofactor is commensurate with
the size of a typical metal-catalyzed transition state. Relying on
a chemogenetic optimization strategy, varying the orientation and
the nature of the biotinylated cofactor within genetically engineered
streptavidin, 12 reactions have been reported by the Ward group thus
far. Recent efforts within our group have focused on extending the
ArM technology to create complex systems for integration into biological
cascade reactions and in vivo.With the long-term
goal of complementing in vivo natural enzymes with
ArMs, we summarize herein three complementary
research lines: (i) With the aim of mimicking complex cross-regulation
mechanisms prevalent in metabolism, we have engineered enzyme cascades,
including cross-regulated reactions, that rely on ArMs. These efforts
highlight the remarkable (bio)compatibility and complementarity of
ArMs with natural enzymes. (ii) Additionally, multiple-turnover catalysis
in the cytoplasm of aerobic organisms was achieved with ArMs that
are compatible with a glutathione-rich environment. This feat is demonstrated
in HEK-293T cells that are engineered with a gene switch that is upregulated
by an ArM equipped with a cell-penetrating module. (iii) Finally,
ArMs offer the fascinating prospect of “endowing organometallic
chemistry with a genetic memory.” With this goal in mind, we
have identified E. coli’s periplasmic space
and surface display to compartmentalize an ArM, while maintaining
the critical phenotype–genotype linkage. This strategy offers
a straightforward means to optimize by directed evolution the catalytic
performance of ArMs. Five reactions have been optimized following
these compartmentalization strategies: ruthenium-catalyzed olefin
metathesis, ruthenium-catalyzed deallylation, iridium-catalyzed transfer
hydrogenation, dirhodium-catalyzed cyclopropanation and carbene insertion
in C–H bonds. Importantly, >100 turnovers were achieved
with
ArMs in E. coli whole cells, highlighting the multiple
turnover catalytic nature of t...